Literature DB >> 28570290

Secondary data analysis: techniques for comparing interventions and their limitations.

Alexander P Cole1, Quoc-Dien Trinh.   

Abstract

PURPOSE OF REVIEW: Secondary data analysis has become increasingly common in health services research, specifically comparative effectiveness research. While a comprehensive study of the techniques and methods for secondary data analysis is a wide-ranging topic, we sought to perform a descriptive study of some key methodological issues related to secondary data analyses and to provide a basic summary of techniques to address them. RECENT
FINDINGS: In this study, we first address common issues seen in analysis of secondary datasets, and limitations of datasets with respect to bias. We cover some strategies for handling missing or incomplete data and a basic summary of three statistical approaches that can be used to address the problem of bias.
SUMMARY: While it is unrealistic for surgeon scientists to aspire to the depth of knowledge of professional statisticians or data scientists, it is important for researchers and clinicians reading to understand some of the common pitfalls and issues when using secondary data to investigate clinical questions. Ultimately, the choice of analytical technique and the particular data sets used should be dictated by the research question and hypothesis being tested. Transparency about data handling and statistical techniques are vital elements of secondary data analysis.

Mesh:

Year:  2017        PMID: 28570290     DOI: 10.1097/MOU.0000000000000407

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  6 in total

1.  Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era.

Authors:  Sean A Fletcher; Sabrina S Harmouch; Marieke J Krimphove; Alexander P Cole; Sebastian Berg; Philipp Gild; Mark A Preston; Guru P Sonpavde; Adam S Kibel; Maxine Sun; Toni K Choueiri; Quoc-Dien Trinh
Journal:  World J Urol       Date:  2018-06-14       Impact factor: 4.226

2.  Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.

Authors:  Alexander P Cole; Peter Herzog; Hari S Iyer; Maya Marchese; Brandon A Mahal; Stuart R Lipsitz; Joshua Nyambose; Susan T Gershman; Mark Kennedy; Gail Merriam; Timothy R Rebbeck; Quoc-Dien Trinh
Journal:  Cancer       Date:  2021-05-17       Impact factor: 6.921

3.  Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma.

Authors:  Marieke J Krimphove; Karl H Tully; David F Friedlander; Maya Marchese; Praful Ravi; Stuart R Lipsitz; Kerry L Kilbridge; Adam S Kibel; Luis A Kluth; Patrick A Ott; Toni K Choueiri; Quoc-Dien Trinh
Journal:  J Immunother Cancer       Date:  2019-11-07       Impact factor: 13.751

4.  Lack of Association between Postoperative Pancreatitis and Other Postoperative Complications Following Pancreaticoduodenectomy.

Authors:  Daegwang Yoo; Seo Young Park; Dae Wook Hwang; Jae Hoon Lee; Ki Byung Song; Woohyung Lee; Yejong Park; Eunsung Jun; Song Cheol Kim
Journal:  J Clin Med       Date:  2021-03-11       Impact factor: 4.241

5.  Association of Care at Minority-Serving vs Non-Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic Cancer in the United States.

Authors:  Alexander P Cole; David-Dan Nguyen; Akezhan Meirkhanov; Mehra Golshan; Nelya Melnitchouk; Stuart R Lipsitz; Kerry L Kilbridge; Adam S Kibel; Zara Cooper; Joel Weissman; Quoc-Dien Trinh
Journal:  JAMA Netw Open       Date:  2019-02-01

6.  Association of surgical approach and prolonged opioid prescriptions in patients undergoing major pelvic cancer procedures.

Authors:  Marieke J Krimphove; Xi Chen; Maya Marchese; David F Friedlander; Adam C Fields; Lina Roa; Daniel Pucheril; Adam S Kibel; Nelya Melnitchouk; Richard D Urman; Luis A Kluth; Prokar Dasgupta; Quoc-Dien Trinh
Journal:  BMC Surg       Date:  2020-10-14       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.